Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1958 2
1961 2
1962 2
1963 4
1964 1
1965 2
1966 4
1967 2
1968 7
1969 9
1970 15
1971 12
1972 12
1973 8
1974 3
1975 8
1976 3
1977 6
1978 5
1979 4
1980 7
1981 8
1982 15
1983 17
1984 27
1985 13
1986 15
1987 23
1988 30
1989 37
1990 27
1991 23
1992 23
1993 35
1994 26
1995 31
1996 46
1997 32
1998 37
1999 43
2000 36
2001 52
2002 57
2003 45
2004 60
2005 49
2006 58
2007 54
2008 82
2009 65
2010 90
2011 100
2012 79
2013 98
2014 84
2015 85
2016 102
2017 79
2018 60
2019 77
2020 98
2021 136
2022 121
2023 100
2024 107
2025 116
2026 36

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,482 results

Results by year

Filters applied: . Clear all
Page 1
Allergen immunotherapy in asthma.
Nakagome K, Nagata M. Nakagome K, et al. Among authors: nagata m. Allergol Int. 2024 Oct;73(4):487-493. doi: 10.1016/j.alit.2024.05.005. Epub 2024 Jul 1. Allergol Int. 2024. PMID: 38955611 Free article. Review.
Raludotatug Deruxtecan, a CDH6-Targeting Antibody-Drug Conjugate with a DNA Topoisomerase I Inhibitor DXd, Is Efficacious in Human Ovarian and Kidney Cancer Models.
Suzuki H, Nagase S, Saito C, Takatsuka A, Nagata M, Honda K, Kaneda Y, Nishiya Y, Honda T, Ishizaka T, Nakamura K, Nakada T, Abe Y, Agatsuma T. Suzuki H, et al. Among authors: nagata m. Mol Cancer Ther. 2024 Mar 4;23(3):257-271. doi: 10.1158/1535-7163.MCT-23-0287. Mol Cancer Ther. 2024. PMID: 38205802 Free PMC article.
Commentary.
Nagata M. Nagata M. Endoscopy. 2025 Jul;57(7):818. doi: 10.1055/a-2556-5074. Epub 2025 Jun 27. Endoscopy. 2025. PMID: 40578336 No abstract available.
Clinical Pharmacology of the Antibody-Drug Conjugate Enfortumab Vedotin in Advanced Urothelial Carcinoma and Other Malignant Solid Tumors.
Tang M, Garg A, Bonate PL, Rosenberg JE, Matsangou M, Kadokura T, Yamada A, Choules M, Pavese J, Nagata M, Tenmizu D, Koibuchi A, Heo N, Wang L, Wojtkowski T, Hanley WD, Poondru S. Tang M, et al. Among authors: nagata m. Clin Pharmacokinet. 2024 Apr;63(4):423-438. doi: 10.1007/s40262-024-01369-0. Epub 2024 Apr 12. Clin Pharmacokinet. 2024. PMID: 38609704 Free PMC article. Review.
Clinical remission of mild-to-moderate asthma: Rates, contributing factors, and stability.
Ishizuka M, Sugimoto N, Kobayashi K, Takeshita Y, Imoto S, Koizumi Y, Togashi Y, Tanaka Y, Nagata M, Hattori S, Uehara Y, Suzuki Y, Toyota H, Ishii S, Nagase H. Ishizuka M, et al. Among authors: nagata m. J Allergy Clin Immunol Glob. 2025 Jan 30;4(2):100431. doi: 10.1016/j.jacig.2025.100431. eCollection 2025 May. J Allergy Clin Immunol Glob. 2025. PMID: 40091885 Free PMC article.
Editorial: Circulating biomarkers in prostate cancer.
Nagata M, Horie S, Ma Y. Nagata M, et al. Front Oncol. 2024 Feb 7;14:1365353. doi: 10.3389/fonc.2024.1365353. eCollection 2024. Front Oncol. 2024. PMID: 38384811 Free PMC article. No abstract available.
2,482 results